İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023 · article

Methods to Evaluate Changes in Mitochondrial Structure and Function in Cancer

Dergi Cancers
ISSN2072-6694
YÖKSİS OpenAlex Açık erişim · gold
Yıl2023
Atıf26OpenAlex
Yüzdelik%89,7
FWCI2,391,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q1

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıCancers
  • Katalog eşleşmesi (ISSN)Cancers
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

Mitochondria are regulators of key cellular processes, including energy production and redox homeostasis. Mitochondrial dysfunction is associated with various human diseases, including cancer. Importantly, both structural and functional changes can alter mitochondrial function. Morphologic and quantifiable changes in mitochondria can affect their function and contribute to disease. Structural mitochondrial changes include alterations in cristae morphology, mitochondrial DNA integrity and quantity, and dynamics, such as fission and fusion. Functional parameters related to mitochondrial biology include the production of reactive oxygen species, bioenergetic capacity, calcium retention, and membrane potential. Although these parameters can occur independently of one another, changes in mitochondrial structure and function are often interrelated. Thus, evaluating changes in both mitochondrial structure and function is crucial to understanding the molecular events involved in disease onset and progression. This review focuses on the relationship between alterations in mitochondrial structure and function and cancer, with a particular emphasis on gynecologic malignancies. Selecting methods with tractable parameters may be critical to identifying and targeting mitochondria-related therapeutic options. Methods to measure changes in mitochondrial structure and function, with the associated benefits and limitations, are summarized.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

26atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 5 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2026 Isolating cancer stem cells in breast cancer models: a study of CD marker expression and Rhodamine 123 as predictors of chemoresistanceAtıf 1 · OpenAlex
  2. 2026 Isolating cancer stem cells in breast cancer models: a study of CD marker expression and Rhodamine 123 as predictors of chemoresistanceAtıf 1 · OpenAlex
  3. 2026 Isolating cancer stem cells in breast cancer models: a study of CD marker expression and Rhodamine 123 as predictors of chemoresistanceAtıf 1 · OpenAlex
  4. 2026 Nivolumab Enhances the Cytotoxicity of Chemotherapeutic Agents in A549 Lung Adenocarcinoma Cell LinesAtıf 0 · OpenAlex
  5. 2026 Nivolumab Enhances the Cytotoxicity of Chemotherapeutic Agents in A549 Lung Adenocarcinoma Cell LinesAtıf 0 · OpenAlex

Yazarlar

12
  1. Brittany P. Rickard 1
  2. Marta Overchuk 2
  3. Vesna Chappell 3
  4. MUSTAFA KEMAL RUHİ BOĞAZİÇİ ÜNİVERSİTESİ 4
  5. Prima Dewi Sinawang 5
  6. Tina Thuy Nguyen Hoang 6
  7. Demir Akın 7
  8. Utkan Demirci 8
  9. Walfre Franco 9
  10. Suzanne E. Fenton 10
  11. Janine H. Santos 11
  12. Imran Rizvi 12